Stockreport

Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7% [Yahoo! Finance]

Amphastar Pharmaceuticals, Inc.  (AMPH) 
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.amphastar.com/investor-relations
PDF Its non-GAAP profit of $0.73 per share was 20.5% below analysts' consensus estimates. Is now the time to buy Amphastar Pharmaceuticals? Find out in our full research r [Read more]